Pathological and clinical impact of neoadjuvant chemoradiotherapy using full-dose gemcitabine and concurrent radiation for resectable pancreatic cancer.
Sho M, Akahori T, Tanaka T, Kinoshita S, Tamamoto T, Nomi T, Yamato I, Hokuto D, Yasuda S, Kawaguchi C, Nishiofuku H, Marugami N, Enomonoto Y, Kasai T, Hasegawa M, Kichikawa K, Nakajima Y.
Sho M, et al. Among authors: yasuda s.
J Hepatobiliary Pancreat Sci. 2013 Feb;20(2):197-205. doi: 10.1007/s00534-012-0532-8.
J Hepatobiliary Pancreat Sci. 2013.
PMID: 22766692